Nasal colonization by Staphylococcus aureus is the major risk factor for disease and transmission. Epidemiological studies have reported a reduced risk of S. aureus carriage in immunocompetent but not in immunocompromised children colonized by Streptococcus pneumoniae. We investigate the hypothesis that the immune response to pneumococcal colonization affects S. aureus colonization. We demonstrate that pneumococcal colonization in mice inhibits subsequent S. aureus acquisition in an antibody-dependent manner and elicits antibody that cross-reacts with S. aureus. We identify the staphylococcal target of cross-reactive antibody as 1-pyrroline-5-carboxylate dehydrogenase (P5CDH), and the homologous immunogen in S. pneumoniae as SP_1119, both of which are conserved dehydrogenases. These antigens are necessary and sufficient to inhibit the acquisition of S. aureus colonization in a mouse model. Our findings demonstrate that immune-mediated cross-reactivity between S. pneumoniae and S. aureus protects against S. aureus nasal acquisition and thus reveal a paradigm for identifying protective antigens against S. aureus.pneumococcus | methicillin-resistant S. aureus | vaccine T he Gram-positive bacterial pathogen Staphylococcus aureus is responsible for significant morbidity, mortality, and excess healthcare costs worldwide. The management of S. aureus disease has become increasingly difficult because of the rising prevalence of methicillin-resistant S. aureus (MRSA), which can account for 60% of S. aureus infections in hospital and community settings (1, 2). Given the limited treatment options for MRSA infection, novel preventative approaches are needed to protect against S. aureus infection and transmission.A predominant risk factor for S. aureus infection and transmission is asymptomatic colonization of the anterior nares (3). Eighty percent of S. aureus invasive infections in humans are caused by the host's colonizing strain (4). However, the specific host and bacterial determinants of S. aureus nasal carriage are not well understood (5). In children, significantly reduced S. aureus colonization rates have been associated with carriage of another member of the upper respiratory tract flora, Streptococcus pneumoniae (6-14). These large and geographically diverse cohorts have demonstrated reproducibly that colonization with S. pneumoniae reduces the risk of S. aureus carriage by approximately half. This interference phenomenon has been reported for both vaccine and nonvaccine serotypes of S. pneumoniae (13). Moreover, pneumococcal vaccination, which reduces S. pneumoniae carriage, has been associated with an increased incidence of S. aureusinduced otitis media in children (15).The etiology of this interference phenomenon between S. pneumoniae and S. aureus colonization is unknown. Although in vitro studies have demonstrated that hydrogen peroxide secreted by S. pneumoniae is bactericidal to S. aureus in coculture (16-18), neither hydrogen peroxide secretion by S. pneumoniae nor hydrogen peroxide sensitivity of S. aureus...